Humana Reports Q4 2025 Loss, Issues Significantly Lower FY 2026 EPS Guidance Due to Star Ratings Headwind

summarizeSummary

Humana reported a net loss for Q4 2025 and provided full-year 2026 adjusted EPS guidance of 'at least $9.00', a substantial decline from $17.14 in 2025, primarily due to the Medicare Advantage Star Ratings headwind.

check_boxKey Events

• Q4 2025 Financial Results

  Humana reported a GAAP net loss per share of $6.61 and an adjusted net loss per share of $3.96 for the fourth quarter of 2025.

• FY 2025 Performance Exceeded Initial Guidance

  The company achieved full-year 2025 adjusted EPS of $17.14, which was in line with management's expectations and exceeded its initial guidance of 'approximately $16.25'.

• Significant FY 2026 EPS Guidance Cut

  Humana introduced full-year 2026 adjusted EPS guidance of 'at least $9.00', representing a substantial year-over-year decline of nearly 48% from $17.14 in 2025.

• Star Ratings Headwind Cited for Decline

  The anticipated decline in 2026 EPS is primarily attributed to the Medicare Advantage Star Ratings headwind for Bonus Year 2026, net of mitigation efforts.

auto_awesomeAnalysis

The core of this filing is the stark contrast between Humana's solid 2025 performance and its significantly reduced 2026 earnings outlook. While the company met its adjusted EPS targets for 2025 and even exceeded initial guidance, the projected full-year 2026 adjusted EPS of 'at least $9.00' marks a substantial decline of nearly 48% from the prior year's $17.14. This severe guidance cut is explicitly linked to the negative impact of the Medicare Advantage Star Ratings for Bonus Year 2026, a known challenge that has now been quantified with a significant financial impact. The company's stock is currently trading below its 52-week low, and this guidance is likely to exert further downward pressure. While strong anticipated Medicare Advantage membership growth of approximately 25% for 2026 is a positive operational indicator, it is insufficient to offset the substantial earnings headwind. Investors will need to closely monitor the company's mitigation strategies for the Star Ratings impact and its ability to translate membership growth into future profitability. The higher projected Insurance segment benefit ratio for 2026 also signals increased costs relative to premiums.